A phase I study of samarium lexidronam/bortezomib combination therapy for the treatment of relapsed or refractory multiple myeloma.
about
Specifications of a continual reassessment method design for phase I trials of combined drugs.Continual reassessment method for partial ordering.Dexamethasone-induced oxidative stress enhances myeloma cell radiosensitization while sparing normal bone marrow hematopoiesisProteasome inhibitors in the treatment of multiple myelomaBeyond Palliation: Therapeutic Applications of 153Samarium-EDTMP.Transcriptomic Signatures of Auger Electron Radioimmunotherapy Using Nuclear Targeting (111)In-Trastuzumab for Potential Combination Therapies.Enhancing radiotherapy through a greater understanding of homologous recombination.Radiosensitization of noradrenaline transporter-expressing tumour cells by proteasome inhibitors and the role of reactive oxygen speciesA preclinical model of CD38-pretargeted radioimmunotherapy for plasma cell malignancies.Manipulation of cellular redox parameters for improving therapeutic responses in B-cell lymphoma and multiple myeloma.A two-dimensional biased coin design for dual-agent dose-finding trials.Escalation with overdose control for phase I drug-combination trials.Improving the dose-myelotoxicity correlation in radiometabolic therapy of bone metastases with 153Sm-EDTMP.
P2860
Q30412231-E790C6D1-1209-4C18-AE9D-76C3084130B1Q30423577-C384F001-8124-4E18-AEC4-2B85EE10496EQ34411693-72603A63-EC2D-48AC-BD8D-B2B383C36A52Q34611676-95D6DB4C-1F17-4DDA-91D5-525FAF5CA9D3Q35057029-FBB54CC4-F986-4075-A7EE-1557510D06A8Q36148279-944B083B-865B-4AC1-A1EA-F26576D60591Q37149845-7521D2D7-F50C-45D0-AF50-B0C243C3022BQ37309407-84BFD246-B8E0-443F-928A-DCB12E67B6B2Q37675882-0E14F333-CCC0-4191-97C1-26B90EE81FBAQ37940343-37220319-E358-411D-AF69-638D9286F1A2Q40749503-6BEC235F-8F5C-44DB-9FE1-C93FC02E6238Q45834856-460D3BD7-9825-4521-AD13-B61BA0966A79Q50485352-24EBB054-4FDB-456E-BED5-578B57AB92F2
P2860
A phase I study of samarium lexidronam/bortezomib combination therapy for the treatment of relapsed or refractory multiple myeloma.
description
2009 nî lūn-bûn
@nan
2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
A phase I study of samarium le ...... r refractory multiple myeloma.
@ast
A phase I study of samarium le ...... r refractory multiple myeloma.
@en
type
label
A phase I study of samarium le ...... r refractory multiple myeloma.
@ast
A phase I study of samarium le ...... r refractory multiple myeloma.
@en
prefLabel
A phase I study of samarium le ...... r refractory multiple myeloma.
@ast
A phase I study of samarium le ...... r refractory multiple myeloma.
@en
P2093
P1476
A phase I study of samarium le ...... r refractory multiple myeloma.
@en
P2093
Christina DiLauro Abaya
Herb Duvivier
James R Berenson
Ori Yellin
Ravi Patel
Regina A Swift
Russell Mapes
Youram Nassir
P304
P356
10.1158/1078-0432.CCR-08-1261
P407
P577
2009-02-01T00:00:00Z